http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-993670-D0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 1999-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afac960de8c94ecea37b5111cce9c029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f235f1ec1e15c7dddfee0bf2ea4a8b64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70ac92fd1f5cccac3b3393e5be4ff2d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f26fd44d90cc67bcc159762ef19db93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0007f5cc9df08bb3acc78d87b9cf2621
publicationDate 1999-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-993670-D0
titleOfInvention Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as a drug for the treatment of AIDS
priorityDate 1997-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414092084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7045

Total number of triples: 34.